Improvements in Treating Narcolepsy, Idiopathic Hypersomnia Through Xywav - Neurology Live

Richard Bogan, MD, FCCP, FAASM, associate clinical professor, University of South Carolina School of Medicine, provided commentary on multi-functional capabilities of Xywav and how the medication has improved care for narcolepsy and idiopathic hypersomnia.

For years, idiopathic hypersomnia, a neurologic sleep disorder characterized by chronic excessive daytime sleepiness (EDS), was treated with off-label wake-promoting therapies. In August 2021, the la… [+8574 chars]

full article...